AI Article Synopsis
- Fecal microbiota transplantation (FMT) is a treatment method that helps restore healthy gut bacteria by transferring fecal microbiota from healthy donors to patients with imbalanced gut flora (dysbiosis).
- FMT has become popular for treating recurrent Clostridium difficile infections (CDI) because of its high success rates and good safety profile.
- There is growing interest in using FMT as a potential treatment for inflammatory bowel diseases (IBD), and recent advancements in its application for both CDI and IBD have been reviewed.
Article Abstract
Fecal microbiota transplantation (FMT) has been emerging as an alternate treatment modality in the management of patients with dysbiosis by restoring abnormal gut microbiota composition through the transplantation of normal fecal microbiota from healthy donors. This technique has lately gained a lot of attention in the treatment of recurrent or refractory infection (CDI) owing to its high success rates combined with its favorable safety profile. FMT has also been attracting the interest of clinicians as a new treatment option for inflammatory bowel diseases (IBD). Here, we reviewed most of the recent advancements in the use of FMT for CDI as well as its use in the treatment of IBD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10802990 | PMC |
| http://dx.doi.org/10.7759/cureus.51004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!